Medicines Guidance A-Z
- Alcohol withdrawal - in patient management protocol (MHS MRG 27)
- Anaphylaxis - recognition and management (MHS 32)
- Antidepressants - stopping & switching (MHS MRG 32)
- Antipsychotics - combination and augmentation guidance (MHS MRG 16)
- Antipsychotics - depot long-acting injection prescribing algorithm (MHS MRG 05)
- Antipsychotics - effective use of first generation depot injections (MHS MRG 04)
- Antipsychotics - high dose monitoring policy (MHS 34)
- Antipsychotics - prescribing in dementia (MHS 31)
- Antipsychotics - use of depot and long acting injections (MHS 30)
- Benzatropine - protocol for unlicensed use (MHS MRG 18)
- Clozapine - 15 day titration regime BLANK (MHS MRG 03.03.02)
- Clozapine - 15 day titration regime STANDARD (MHS MRG 03.03.01)
- Clozapine - developing a treatment plan for managing off licence use (MHS MRG 03.04)
- Clozapine - options for initiation (MHS MRG 03.03)
- Clozapine - out patient prescription form (MHS MRG 03.05)
- Clozapine - patient holiday supplies (MHS MRG 03.10)
- Clozapine - patient information standards (MHS MRG 03.09)
- Clozapine - plasma monitoring guidance (MHS MRG 03 07)
- Clozapine - protocol for rechallenge following a neutropenic episode (MHS MRG 03.11)
- Clozapine - protocol for the use of liquid (MHS MRG 03.06)
- Clozapine - protocol for use of oro-dispersible tablets (MHS MRG 33)
- Clozapine - service standards (MHS MRG 03.01)
- Clozapine - side effects monitoring care plan (MHS MRG 03.02)
- Clozapine induced constipation - assessment and treatment (MHS MRG 03.08)
- Controlled drugs - advice for checking stock (MHS MRG 10)
- Covert medication and dysphagia - safe and cost effective administration (MHS MRG 02)
- Covert medication policy (MHS 53)
- Emergency cupboard list and procedure for out of hours access (MHS MRG 12)
- Fluphenazine decanoate - protocol for unlicensed use (MHS MRG 35)
- Haloperidol and QTc interval prolongation (MHS MRG 07)
- Insomnia - management (MHS 35)
- Insulin - safer use (MHS MRG 21)
- Intramuscular medication for acutely disturbed behaviour (MHS 40)
- Lithium - good practice standards (MHS MRG 26)
- Lithium bundle (MHS MRG 24)
- Lithium- patient information standards (MHS MRG 34)
- Medication given out with prescribed times - administration and recording (MHS MRG 15)
- Midazolam - intramuscular use for acutely disturbed behaviour (MHS MRG 06)
- Neuroleptic malignant syndrome (MHS MRG 31)
- Non-formulary and unlicensed medicines - advice on access (MHS MRG 08)
- Non-formulary request form (MHS MRG 08.01)
- Nurse dispensing outwith pharmacy hours (MHS MRG 14)
- Off-label unlicensed prescribing guidance in MHS (MHS MRG 25)
- Olanzapine - protocol for use of unlicensed injection (MHS MRG 23)
- Opioids - safer use (MHS MRG 22)
- Paracetamol overdose guidance (MHS MRG 17)
- Pass medication - procedure for ordering (MHS 37)
- Patients own drugs - procedure for use (MHS 38)
- Physical healthcare policy (MHS 20)
- Pirenzepine - protocol for unlicensed use (MHS MRG 19)
- Prescribing as required psychotropic drugs (MHS MRG 28)
- Prescription Sheet NHSGGC Mental Health - instructions for use (MHS MRG 09)
- Problematic drug users - management of adults in NHSGGC acute hospitals (MHS MRG 11)
- Response ward emergency tray locations (MHS MRG 13)
- Safe secure handling of medicines in hospital wards (MHS MRG 01)
- Serotonin syndrome (MHS MRG 30)
- Symptomatic relief policy - adults and older adults (MHS 28)
- Thioridazine - protocol for unlicensed use (MHS MRG 20)
- Valproate pregnancy prevention programme
- Zuclopenthixol Acetate (Clopixol Acuphase) (MHS 33)